NASDAQ:IRON Disc Medicine (IRON) Stock Price, News & Analysis $83.28 +2.12 (+2.61%) Closing price 11/4/2026 04:00 PM EasternExtended Trading$84.89 +1.61 (+1.93%) As of 11/4/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Disc Medicine Stock (NASDAQ:IRON) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Disc Medicine alerts:Sign Up Key Stats Today's Range$80.78▼$83.5750-Day Range$55.74▼$83.2852-Week Range$40.00▼$99.50Volume1.43 million shsAverage Volume1.56 million shsMarket Capitalization$3.20 billionP/E RatioN/ADividend YieldN/APrice Target$122.70Consensus RatingModerate Buy Company Overview Disc Medicine, Inc. (NASDAQ: IRON) is a clinical-stage biopharmaceutical company focused on developing treatments for serious hematologic diseases. Its research is centered on the biology of red blood cell production and iron homeostasis, with the goal of addressing disorders in which abnormal iron regulation or ineffective erythropoiesis contributes to disease. The company's pipeline includes bitopertin, an investigational oral therapy designed to enhance red blood cell production through inhibition of glycine transporter 1. Disc Medicine has evaluated bitopertin in conditions including erythropoietic protoporphyria, a rare disorder associated with toxic protoporphyrin accumulation and severe light sensitivity, as well as other hematologic diseases. Disc Medicine is also developing DISC-0974, an investigational antibody targeting hemojuvelin, a regulator of hepcidin and iron metabolism. The company is studying this program for anemia associated with inflammation and other hematologic conditions in which restricted iron availability may limit red blood cell production. Disc Medicine is headquartered in Waltham, Massachusetts, and conducts research and clinical development activities through collaborations and clinical studies in the United States and other regions.AI Generated. May Contain Errors. Read More Disc Medicine Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreIRON MarketRank™: 1.84492695349 of 5 starsDisc Medicine scored higher than 37% of companies evaluated by MarketBeat, and ranked 658th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingDisc Medicine has received a consensus rating of Moderate Buy. The company's average rating score is 2.77, and is based on no strong buy ratings, 11 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialDisc Medicine has a consensus price target of $122.70, representing about 47.3% upside from its current price of $83.28.Amount of Analyst CoverageDisc Medicine has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Disc Medicine's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Disc Medicine are expected to decrease in the coming year, from ($6.61) to ($7.14) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Disc Medicine is -12.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Disc Medicine is -12.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDisc Medicine has a P/B Ratio of 4.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Disc Medicine's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted202.05% of the float of Disc Medicine has been sold short.Short Interest Ratio / Days to CoverDisc Medicine has a short interest ratio ("days to cover") of 10.63, which indicates bearish sentiment.Change versus previous monthShort interest in Disc Medicine has recently increased by 2.57%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDisc Medicine does not currently pay a dividend.Dividend GrowthDisc Medicine does not have a long track record of dividend growth. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 5 news articles for Disc Medicine this week, compared to 7 articles on an average week.Search Interest10 people have searched for IRON on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Disc Medicine insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $13,591,034.00 in company stock.Percentage Held by Insiders3.76% of the stock of Disc Medicine is held by insiders.Percentage Held by Institutions83.70% of the stock of Disc Medicine is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Disc Medicine's insider trading history. Receive IRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Disc Medicine and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IRON Stock News HeadlinesDisc Medicine Announces Multiple Presentations Across Portfolio at the 68th American Society of Hematology (ASH) Annual MeetingNovember 4 at 9:20 AM | markets.businessinsider.comDisc Medicine Announces Multiple Presentations Across Portfolio at the 68th American Society of Hematology (ASH) Annual MeetingNovember 4 at 9:05 AM | globenewswire.comHow one gold strategy paid out 1127 dollars in a monthGold usually only pays off once its price climbs, and only after you sell. Tim Plaehn found a different route. A little-known 15 dollar investment turns gold's price swings into cash payments that can arrive every Friday. In one recent month, those payments could have added up to 1,127 dollars. No waiting for gold to rise, no need to sell anything to collect. | Investors Alley (Ad)Disc Medicine to Participate in Upcoming Investor ConferencesNovember 2 at 8:30 AM | globenewswire.comDisc Medicine (IRON) Receives a Buy from Leerink PartnersOctober 29, 2026 | theglobeandmail.comDisc Medicine (NASDAQ:IRON) Stock: Insider Kevin Bitterman Sells 5,312 SharesOctober 22, 2026 | insidertrades.comDisc Medicine, Inc. (IRON) Discusses Topline Results of APOLLO Phase III Trial of Bitopertin in EPP - SlideshowOctober 21, 2026 | seekingalpha.comDisc Medicine Announces Pricing of Upsized $450 Million Public OfferingOctober 20, 2026 | quiverquant.comQSee More Headlines IRON Stock Analysis - Frequently Asked Questions How have IRON shares performed this year? Disc Medicine's stock was trading at $79.41 at the beginning of the year. Since then, IRON shares have increased by 4.9% and is now trading at $83.28. How were Disc Medicine's earnings last quarter? Disc Medicine, Inc. (NASDAQ:IRON) posted its quarterly earnings results on Thursday, July, 30th. The company reported ($1.54) earnings per share for the quarter, topping analysts' consensus estimates of ($1.71) by $0.17. When did Disc Medicine IPO? Disc Medicine (IRON) raised $105 million in an initial public offering (IPO) on Wednesday, August 12th 2020. The company issued 10,500,000 shares at $10.00 per share. Who are Disc Medicine's major shareholders? Disc Medicine's top institutional shareholders include Assenagon Asset Management S.A. (2.92%), Pictet Asset Management Holding SA (0.33%), Alps Advisors Inc. (0.13%) and Pinnacle Associates Ltd. (0.09%). Insiders that own company stock include Venture Fund X LP Atlas, Orbimed Advisors Llc, John D Quisel, Mona Ashiya, Pamela Stephenson, William Jacob Savage, Jean M Franchi, Jonathan Yen-Wen Yu, Rahul Khara, Kevin Bitterman, Joanne Bryce and William Richard White. View institutional ownership trends. How do I buy shares of Disc Medicine? Shares of IRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Disc Medicine own? Based on aggregate information from My MarketBeat watchlists, some other companies that Disc Medicine investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Oracle (ORCL), Taiwan Semiconductor Manufacturing (TSM), Intuitive Surgical (ISRG) and Kratos Defense & Security Solutions (KTOS). Company Calendar Last Earnings7/30/2026Today11/04/2026Next Earnings (Estimated)11/05/20263rd Annual Guggenheim Healthcare Innovation Conference11/09/2026Stifel 2026 Healthcare Conference11/12/2026UBS Global Biopharma Conference 202611/17/2026Jefferies Global Healthcare Conference11/18/2026Investor update12/16/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 2 weeks, IRON's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:IRON CIK1816736 Webwww.discmedicine.com Phone(617) 674-9274FaxN/AEmployees165Year Founded2017Price Target and Rating Average Price Target for Disc Medicine$122.70 High Price Target$170.00 Low Price Target$92.00 Potential Upside/Downside+47.3%Consensus RatingModerate Buy Rating Score (0-4)2.77 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($6.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$212.18 million Net MarginsN/A Pretax MarginN/A Return on Equity-37.17% Return on Assets-33.65% Debt Debt-to-Equity Ratio0.09 Current Ratio24.14 Quick Ratio24.14 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$19.52 per share Price / Book4.27Miscellaneous Outstanding Shares38,390,000Free Float36,949,000Market Cap$3.20 billion OptionableOptionable Beta0.96 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:IRON) was last updated on 11/4/2026 by MarketBeat.com Staff. From Our PartnersThe 401k Email 70 Million Investors Might DeleteAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis little-known fund tracks gold and pays out weeklyA little-known $15 fund tied to gold could pay you cash every Friday, no mining stock required. In one rece...Investors Alley | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRON Stock Alerts